The goal of this observational study is to evaluate the feasibility and clinical utility of radiomics to diagnose peri-lesion tumour infiltration of tumours in participants with a suspect of Bone Cancer Tumor or Soft Tissue Sarcoma (STS).
The main questions it aims to answer are:
* is radiomics able to identify the ratio of participants truly diagnosed as positive to all those who had positive test results? * is radiomics able to identify the likelihood that a participant who has a negative test result indeed does not have the disease?
Participants eligible for this study will get a MRI as part of their regular medical care. The only difference is that their data will be recorded and anonymously analyzed.
Age over 18
suspect of soft tissue sarcoma with a indication for surgical treatment
suspect of bone cancer tumor with a indication for surgical treatment
To give informed consent
simultaneous cancer or history of cancer in the last 5 years
acute or chronic serious conditions that could
renal failure without dialysis
history of allergy to a paramagnetic contrast agent